[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Docetaxel Market in France - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 92 pages | ID: D4C9949D9650EN
Market Monitor Global

US$ 2,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
This report contains market size and forecasts of Docetaxel in France, including the following market information:
France Docetaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
France Docetaxel Market Consumption, 2015-2020, 2021-2026, (K Units)
France Docetaxel Production Capacity, 2015-2020, 2021-2026, (K Units)
Top Five Competitors in France Docetaxel Market 2019 (%)
The global Docetaxel market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Docetaxel market size in France was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Docetaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Docetaxel production and consumption in France

Total Market by Segment:

France Docetaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
France Docetaxel Market Segment Percentages, By Type, 2019 (%)
  • 20 mg/ml
  • 40 mg/ml
  • 60 mg/ml
France Docetaxel Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)
France Docetaxel Market Segment Percentages, By Application, 2019 (%)
  • Breast Cancer
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Other
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Docetaxel Market Competitors Revenues in France, by Players 2015-2020 (Estimated), ($ millions)
Total Docetaxel Market Competitors Revenues Share in France, by Players 2019 (%)
Total France Docetaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total France Docetaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
  • Hengrui Medicine
  • Sanofi
  • Qilu Pharma
  • Shenzhen Main Luck Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Docetaxel Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 France Docetaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: FRANCE DOCETAXEL OVERALL MARKET SIZE

2.1 France Docetaxel Market Size: 2020 VS 2026
2.2 France Docetaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 France Docetaxel Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Docetaxel Players in France (including Foreign and Local Companies)
3.2 Top France Docetaxel Companies Ranked by Revenue
3.3 France Docetaxel Revenue by Companies (including Foreign and Local Companies)
3.4 France Docetaxel Sales by Companies (including Foreign and Local Companies)
3.5 France Docetaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Docetaxel Companies in France, by Revenue in 2019
3.7 France Manufacturers Docetaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Docetaxel Players in France
  3.8.1 List of France Tier 1 Docetaxel Companies
  3.8.2 List of France Tier 2 and Tier 3 Docetaxel Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - France Docetaxel Market Size Markets, 2020 & 2026
  4.1.2 20 mg/ml
  4.1.3 40 mg/ml
  4.1.4 60 mg/ml
4.2 By Type - France Docetaxel Revenue & Forecasts
  4.2.1 By Type - France Docetaxel Revenue, 2015-2020
  4.2.2 By Type - France Docetaxel Revenue, 2021-2026
  4.2.3 By Type - France Docetaxel Revenue Market Share, 2015-2026
4.3 By Type - France Docetaxel Sales & Forecasts
  4.3.1 By Type - France Docetaxel Sales, 2015-2020
  4.3.2 By Type - France Docetaxel Sales, 2021-2026
  4.3.3 By Type - France Docetaxel Sales Market Share, 2015-2026
4.4 By Type - France Docetaxel Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - France Docetaxel Market Size, 2020 & 2026
  5.1.2 Breast Cancer
  5.1.3 Prostate Cancer
  5.1.4 Non-small Cell Lung Cancer
  5.1.5 Other
5.2 By Application - France Docetaxel Revenue & Forecasts
  5.2.1 By Application - France Docetaxel Revenue, 2015-2020
  5.2.2 By Application - France Docetaxel Revenue, 2021-2026
  5.2.3 By Application - France Docetaxel Revenue Market Share, 2015-2026
5.3 By Application - France Docetaxel Sales & Forecasts
  5.3.1 By Application - France Docetaxel Sales, 2015-2020
  5.3.2 By Application - France Docetaxel Sales, 2021-2026
  5.3.3 By Application - France Docetaxel Sales Market Share, 2015-2026
5.4 By Application - France Docetaxel Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Hengrui Medicine
  6.1.1 Hengrui Medicine Corporate Summary
  6.1.2 Hengrui Medicine Business Overview
  6.1.3 Hengrui Medicine Docetaxel Major Product Offerings
  6.1.4 Hengrui Medicine Sales and Revenue in France (2015-2020)
  6.1.5 Hengrui Medicine Key News
6.2 Sanofi
  6.2.1 Sanofi Corporate Summary
  6.2.2 Sanofi Business Overview
  6.2.3 Sanofi Docetaxel Major Product Offerings
  6.2.4 Sanofi Sales and Revenue in France (2015-2020)
  6.2.5 Sanofi Key News
6.3 Qilu Pharma
  6.3.1 Qilu Pharma Corporate Summary
  6.3.2 Qilu Pharma Business Overview
  6.3.3 Qilu Pharma Docetaxel Major Product Offerings
  6.3.4 Qilu Pharma Sales and Revenue in France (2015-2020)
  6.3.5 Qilu Pharma Key News
6.4 Shenzhen Main Luck Pharma
  6.4.1 Shenzhen Main Luck Pharma Corporate Summary
  6.4.2 Shenzhen Main Luck Pharma Business Overview
  6.4.3 Shenzhen Main Luck Pharma Docetaxel Major Product Offerings
  6.4.4 Shenzhen Main Luck Pharma Sales and Revenue in France (2015-2020)
  6.4.5 Shenzhen Main Luck Pharma Key News
6.5 Jiangsu Aosaikang Pharma
  6.5.1 Jiangsu Aosaikang Pharma Corporate Summary
  6.5.2 Jiangsu Aosaikang Pharma Business Overview
  6.5.3 Jiangsu Aosaikang Pharma Docetaxel Major Product Offerings
  6.5.4 Jiangsu Aosaikang Pharma Sales and Revenue in France (2015-2020)
  6.5.5 Jiangsu Aosaikang Pharma Key News

7 DOCETAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Docetaxel Production Capacity and Value in France, Situation Analysis and Prediction, 2015-2026
  7.1.1 France Docetaxel Production Capacity, 2015-2026
  7.1.2 France Docetaxel Production 2015-2026
  7.1.3 France Docetaxel Production Value 2015-2026
7.2 Key Local Docetaxel Manufacturers in France
  7.2.1 France Key Local Docetaxel Manufacturers Production Capacity
  7.2.2 France Key Local Docetaxel Manufacturers Production
  7.2.3 France Key Local Docetaxel Manufacturers Production Value
  7.2.4 The Proportion of Docetaxel Production Sold in France and Sold Other Than France by Manufacturers
7.3 Docetaxel Export and Import in France
  7.3.1 France Docetaxel Export Market
  7.3.2 France Docetaxel Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for France Docetaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON DOCETAXEL SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Docetaxel Distributors and Sales Agents in France

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Docetaxel in France
Table 2. Top Players in France, Ranking by Revenue (2019)
Table 3. France Docetaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. France Docetaxel Revenue Share by Companies, 2015-2020
Table 5. France Docetaxel Sales by Companies, (K Units), 2015-2020
Table 6. France Docetaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Docetaxel Price (2015-2020) (USD/Unit)
Table 8. France Manufacturers Docetaxel Product Type
Table 9. List of France Tier 1 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of France Tier 2 and Tier 3 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Docetaxel Revenue in France (US$, Mn), 2015-2020
Table 12. By Type - Docetaxel Revenue in France (US$, Mn), 2021-2026
Table 13. By Type - Docetaxel Sales in France (K Units), 2015-2020
Table 14. By Type - Docetaxel Sales in France (K Units), 2021-2026
Table 15. By Application - Docetaxel Revenue in France, (US$, Mn), 2015-2020
Table 16. By Application - Docetaxel Revenue in France, (US$, Mn), 2021-2026
Table 17. By Application - Docetaxel Sales in France, (K Units), 2015-2020
Table 18. By Application - Docetaxel Sales in France, (K Units), 2021-2026
Table 19. Hengrui Medicine Corporate Summary
Table 20. Hengrui Medicine Docetaxel Product Offerings
Table 21. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Sanofi Corporate Summary
Table 23. Sanofi Docetaxel Product Offerings
Table 24. Sanofi Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Qilu Pharma Corporate Summary
Table 26. Qilu Pharma Docetaxel Product Offerings
Table 27. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Shenzhen Main Luck Pharma Corporate Summary
Table 29. Shenzhen Main Luck Pharma Docetaxel Product Offerings
Table 30. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Jiangsu Aosaikang Pharma Corporate Summary
Table 32. Jiangsu Aosaikang Pharma Docetaxel Product Offerings
Table 33. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Docetaxel Production Capacity (K Units) of Local Manufacturers in France, 2015-2020
Table 35. Docetaxel Production (K Units) of Local Manufacturers in France, 2015-2020
Table 36. France Docetaxel Production Market Share of Local Manufacturers, 2015-2020
Table 37. Docetaxel Production Value (US$, Mn) of Local Manufacturers in France, 2015-2020
Table 38. France Docetaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 39. The Percentage of Docetaxel Production Sold in France and Sold Other Than France by Manufacturers
Table 40. The Percentage of Docetaxel Production Sold in France and Sold Other Than France by Manufacturers
Table 41. Dangeguojia Docetaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 42. Raw Materials and Suppliers
Table 43. Docetaxel Downstream Clients in France
Table 44. Docetaxel Distributors and Sales Agents in France

LIST OF FIGURES

Figure 1. Docetaxel Segment by Type
Figure 2. Docetaxel Segment by Application
Figure 3. Dangeguojia Docetaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Docetaxel Market Size in France, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. France Docetaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Docetaxel Sales in France: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Docetaxel Revenue in 2019
Figure 9. By Type - France Docetaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - France Docetaxel Market Share, 2015-2020
Figure 11. By Type - France Docetaxel Market Share, 2020-2026
Figure 12. By Type - France Docetaxel Price (USD/Unit), 2015-2026
Figure 13. By Application - Docetaxel Revenue in France (US$, Mn), 2020 & 2026
Figure 14. By Application - France Docetaxel Market Share, 2015-2020
Figure 15. By Application - France Docetaxel Market Share, 2020-2026
Figure 16. By Application -France Docetaxel Price (USD/Unit), 2015-2026
Figure 17. France Docetaxel Production Capacity (K Units), 2015-2026
Figure 18. France Docetaxel Actual Output (K Units), 2015-2026
Figure 19. France Docetaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of France Docetaxel Export Destination, 2019
Figure 21. The Source of Imports of France Docetaxel, 2019
Figure 22. PEST Analysis for France Docetaxel Market in 2020
Figure 23. Docetaxel Market Opportunities & Trends in France
Figure 24. Docetaxel Market Drivers in France
Figure 25. Docetaxel Market Restraints in France
Figure 26. Docetaxel Industry Value Chain


More Publications